cat no | io1002
ioSkeletal Myocytes, are human iPSC-derived skeletal myocytes deterministically programmed using opti-ox technology. Skeletal myocytes are delivered cryopreserved, upon revival the cells rapidly mature forming elongated striated, multinucleated muscle cells that contract within 10 days. Easy to culture, skeletal myocytes consistently exhibit high population purity expressing key myofilament proteins such as Desmin and Myosin Heavy Chain (MHC).
ioSkeletal Myocytes provide a source of highly-defined, consistent and reliable human muscle cells for research, disease modelling and high-throughput screening across areas such as muscle, neuromuscular, and associated metabolic disorders.
Confidently investigate your phenotype of interest across multiple clones with our disease model clone panel. Detailed characterisation data (below) and bulk RNA sequencing data (upon request) help you select specific clones if required.
per vial
A maximum number of 20 vials applies. If you would like to order more than 20 vials, please contact us at orders@bit.bio.
Consistent
Batch-to-batch reproducibility and homogeneity create a stable human model for the study of muscle, neuromuscular, and associated metabolic disorders.
Quick
Form striated, multinucleated, myocytes by day 10 post revival, that contract in response to acetylcholine.
Easy-to-use
Cells arrive programmed to rapidly mature upon revival. One medium is required in a two-step protocol.
ioSkeletal Myocytes generated by transcription factor-driven deterministic programming of iPSCs using opti-ox technology
ioSkeletal Myocytes express skeletal myocyte-specific markers
Cells demonstrate classical myocyte morphology
Cells demonstrate gene expression of key myogenic markers following deterministic programming
Cells are suitable for phenotypic based high-throughput screening
Cells express the insulin regulated glucose transporter GLUT4, critical for metabolic studies
In vitro human muscle cells suitable for contractility assays
Available in two vial sizes, tailored to suit your experimental needs with minimal waste
Bernard, et al
bit.bio
2024
bit.bio
V5
bit.bio
2023
Dr Marieke Aarts | Principal Scientist | Bi/ond
Amanda Turner | Senior Product Manager | bit.bio
Read this blog on skeletal myocytes cell culture for our top tips on careful handling, cell plating and media changes to achieve success from the outset.
Dr Shushant Jain
Group Leader | In Vitro Biology | Charles River, 2021
Amy Rochford
PhD Neural Engineering and Bioelectronics | Cambridge University
Dr Michael Duchen
Professor of Physiology | University College London